Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B

被引:0
作者
McGinnis, MR
Nordoff, N
Li, RK
Pasarell, L
Warnock, DW
机构
[1] Univ Texas, Med Branch, Dept Pathol, Galveston, TX 77555 USA
[2] Ctr Dis Control & Prevent, Mycot Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA
关键词
amphotericin B; itraconazole; Sporothrix schenckii; voriconazole;
D O I
10.1080/714031044
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
One hundred clinical isolates of Sporothrix schenckii were tested against voriconazole, itraconazole and amphotericin B using a modification of the NCCLS M27-A in vitro yeast susceptibility testing procedure. NCCLS M38-P for moulds was not used because yeast forms may have been present when the test isolates were incubated at 35 +/-1 degreesC. The minimum inhibitory concentration (MIC) values were: voriconazole 0.5-8 (geometric mean titer 6.50) mug ml(-1); itraconazole 0.03-8 (geometric mean titer 1.56) mug ml(-1); and amphotericin B 0.25-2 (geometric mean titer 1.23) mug, ml(-1). The minimum fungicidal concentration (MFC) values were: voriconazole 2-8 (geometric mean titer 7.67) mug ml(-1); itraconazole 0.125-8 (geometric mean titer 7.41) l mug ml(-1); and amphotericin B 0.125-2 (geometric mean titer 1.53) mug ml(-1). Based upon MIC values, sensitivity to amphotericin B is strain-dependent. S. schenckii is more sensitive to itraconazole than voriconazole based upon a comparison of MIC geometric means, even though the MIC ranges were essentially the same.
引用
收藏
页码:369 / 371
页数:3
相关论文
共 50 条
  • [21] Comparison of disk diffusion, E-test and broth microdilution test in determination of susceptibility of Aspergillus species to amphotericin B, itraconazole and voriconazole
    Ozkutuk, A.
    Ergon, C.
    Metin, D. Y.
    Yucesoy, M.
    Polat, S. H.
    JOURNAL OF CHEMOTHERAPY, 2008, 20 (01) : 87 - 92
  • [22] In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. isolated from patients with haematological malignancies in Tunisia
    Gheith, Soukeina
    Saghrouni, Fatma
    Bannour, Wadiaa
    Ben Youssef, Yosra
    Khelif, Abderrahim
    Normand, Anne-Cecile
    Piarroux, Renaud
    Ben Said, Moncef
    Njah, Mansour
    Ranque, Stephane
    SPRINGERPLUS, 2014, 3
  • [23] Sporothrix schenckii and Sporotrichosis
    de Lima Barros, Monica Bastos
    Paes, Rodrigo de Almeida
    Schubach, Armando Oliveira
    CLINICAL MICROBIOLOGY REVIEWS, 2011, 24 (04) : 633 - 654
  • [24] Sporothrix Schenckii Infection
    Huang, Xiao-Li
    Zhang, Guo-Ming
    CLINICAL LABORATORY, 2018, 64 (11-12) : 1963 - 1964
  • [25] Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole
    Kantarcioglu, A. Serda
    Boekhout, Teun
    Yucel, Ayhan
    Altas, Kemal
    MEDICAL MYCOLOGY, 2009, 47 (02) : 169 - 176
  • [26] Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin
    Ozdemir, Havva Gul
    Oz, Yasemin
    Ilkit, Macit
    Kiraz, Nuri
    MEDICAL MYCOLOGY, 2012, 50 (02) : 130 - 135
  • [27] Pansinusitis due to Sporothrix schenckii
    Kumar, R
    Kaushal, V
    Chopra, H
    Gupta, R
    Chhina, DK
    Kaushal, RK
    Mohan, U
    MYCOSES, 2005, 48 (01) : 85 - 88
  • [28] Interference of melanin in the susceptibility profile of Sporothrix species to amphotericin B
    Nunes Mario, Debora Alves
    Vianna Santos, Roberto Christ
    Denardi, Laura Bedin
    Vaucher, Rodrigo de Almeida
    Santurio, Janio Morais
    Alves, Sydney Hartz
    REVISTA IBEROAMERICANA DE MICOLOGIA, 2016, 33 (01): : 21 - 25
  • [29] Comparison of Sensititre YeastOne® with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus
    Guinea, Jesus
    Pelaez, Teresa
    Alcala, Luis
    Bouza, Emilio
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 56 (01) : 53 - 55
  • [30] Synergism of CAY-1 with amphotericin B and itraconazole
    De Lucca, A. J.
    Blanda, J. M.
    Boue, S.
    Vigo, C. B.
    Cleveland, T. E.
    Walsh, T. J.
    CHEMOTHERAPY, 2006, 52 (06) : 285 - 287